HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea S Kim Selected Research

izencitinib

1/2022Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical Species.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea S Kim Research Topics

Disease

1Sickle Cell Anemia (Hemoglobin S Disease)
11/2022
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2022
1Peripheral Arterial Disease
11/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Carcinogenesis
01/2008
1Adenocarcinoma
01/2008
1Neoplasms (Cancer)
11/2006

Drug/Important Bio-Agent (IBA)

1inclacumabIBA
11/2022
1Janus Kinase InhibitorsIBA
01/2022
1Janus KinasesIBA
01/2022
1izencitinibIBA
01/2022
1methylureaIBA
01/2008
1Perphenazine (Trilafon)FDA LinkGeneric
01/2008
1ProlactinIBA
01/2008
1Antipsychotic Agents (Antipsychotics)IBA
01/2008
1Biomarkers (Surrogate Marker)IBA
11/2006

Therapy/Procedure

1Therapeutics
11/2022